Predictive Biomarkers for Checkpoint Blockade in Urothelial Cancer: A Systematic Review

Authors:

Abstract
Background:Immune checkpoint inhibitors have had a major impact on the management of advanced urothelial cancer. Despite their impact, only a minority of patients derive benefit. In this context, predictive biomarkers that can assist in patient selection are needed. This systematic review aims to survey the current biomarkers that have been investigated in clinical studies, and their potential for patient selection.Methods:We conducted a search of MEDLINE and EMBASE, as well as a manual review of major meeting abstracts, for studies in humans of immune checkpoint inhibitors given for urothelial cancer that included both biomarkers and clinical outcomes. Studies had to report the correlation between biomarkers and outcomes to be included. Results published in abstract form only were included since several important biomarker studies have yet to be published.Results:Our systematic review retrieved 1236 studies, of which 921 were unique and screened; 144 met criteria for full review, and 25 were incl...